Maryse Power

709 total citations
44 papers, 384 citations indexed

About

Maryse Power is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Maryse Power has authored 44 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 21 papers in Genetics and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Maryse Power's work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (16 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Maryse Power is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (16 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Maryse Power collaborates with scholars based in Canada, Saudi Arabia and Switzerland. Maryse Power's co-authors include John D. Shepherd, Kevin Song, Heather J. Sutherland, Donna L. Forrest, Stephen H. Nantel, Thomas J. Nevill, Donna E. Hogge, Michael J. Barnett, Cynthia L. Toze and Joseph M. Connors and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Maryse Power

41 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryse Power Canada 12 232 168 143 132 71 44 384
Catia Bigazzi Italy 11 181 0.8× 184 1.1× 148 1.0× 121 0.9× 27 0.4× 16 368
Carlos E. Bueso-Ramos United States 6 149 0.6× 171 1.0× 147 1.0× 73 0.6× 27 0.4× 12 334
Fontanet Bijou France 11 131 0.6× 217 1.3× 234 1.6× 233 1.8× 39 0.5× 46 467
Márcia Torresan Delamain Brazil 10 139 0.6× 126 0.8× 74 0.5× 69 0.5× 68 1.0× 53 272
Patricia Martin‐Regueira United States 9 332 1.4× 206 1.2× 63 0.4× 123 0.9× 99 1.4× 21 464
Angela Volkert United States 6 366 1.6× 313 1.9× 64 0.4× 122 0.9× 163 2.3× 16 480
E. Dorey United Kingdom 7 124 0.5× 117 0.7× 214 1.5× 220 1.7× 34 0.5× 11 402
J. Janssen Netherlands 9 285 1.2× 222 1.3× 47 0.3× 70 0.5× 111 1.6× 11 412
Hien K. Duong United States 8 261 1.1× 107 0.6× 29 0.2× 100 0.8× 62 0.9× 30 425

Countries citing papers authored by Maryse Power

Since Specialization
Citations

This map shows the geographic impact of Maryse Power's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryse Power with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryse Power more than expected).

Fields of papers citing papers by Maryse Power

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryse Power. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryse Power. The network helps show where Maryse Power may publish in the future.

Co-authorship network of co-authors of Maryse Power

This figure shows the co-authorship network connecting the top 25 collaborators of Maryse Power. A scholar is included among the top collaborators of Maryse Power based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryse Power. Maryse Power is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wan, Bo, Yasser Abou Mourad, Shanee Chung, et al.. (2024). Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products. Cytotherapy. 26(10). 1210–1216. 2 indexed citations
2.
Kuchenbauer, Florian, Ryan J. Stubbins, Shanee Chung, et al.. (2023). Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort. Blood. 142(Supplement 1). 1482–1482. 3 indexed citations
3.
Mourad, Yasser Abou, Donna L. Forrest, Alina S. Gerrie, et al.. (2021). Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population. Clinical Lymphoma Myeloma & Leukemia. 21(7). 476–482. 2 indexed citations
4.
Hogge, Donna E., Donna L. Forrest, Sujaatha Narayanan, et al.. (2020). Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian Cohort. Clinical Lymphoma Myeloma & Leukemia. 20(7). e427–e436. 1 indexed citations
5.
Sutherland, Heather J., Yasser Abou Mourad, Michael J. Barnett, et al.. (2019). Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center. Clinical Lymphoma Myeloma & Leukemia. 19(12). 784–790. 12 indexed citations
6.
7.
Alzahrani, Musa, Maryse Power, Yasser Abou Mourad, et al.. (2018). Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience. Biology of Blood and Marrow Transplantation. 24(6). 1209–1215. 14 indexed citations
8.
9.
Lad, Deepesh, Yasser Abou Mourad, Michael J. Barnett, et al.. (2016). Pre-Transplant Vitamin D Deficiency is Associated with Inferior Overall Survival but not Associated with Relapse Free Survival or Cumulative Incidence of GVHD Post Adult Hematopoietic Cell Transplantation for Hematological Malignancies. Biology of Blood and Marrow Transplantation. 22(3). S334–S334. 1 indexed citations
10.
Kliman, David, Michael J. Barnett, Raewyn Broady, et al.. (2016). Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemia. Leukemia & lymphoma. 58(4). 909–915. 3 indexed citations
11.
Nair, Anish, Michael J. Barnett, Raewyn Broady, et al.. (2015). Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors. Biology of Blood and Marrow Transplantation. 21(8). 1437–1444. 17 indexed citations
12.
Gerrie, Alina S., Maryse Power, John D. Shepherd, et al.. (2014). Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma. Annals of Oncology. 25(11). 2218–2223. 33 indexed citations
13.
14.
Tantiworawit, Adisak, Maryse Power, Michael J. Barnett, et al.. (2011). Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy. Leukemia & lymphoma. 53(7). 1321–1326. 13 indexed citations
15.
Venner, Christopher P., Joseph M. Connors, Heather J. Sutherland, et al.. (2010). Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months). Leukemia & lymphoma. 52(1). 34–41. 25 indexed citations
16.
17.
Nevill, Thomas J., John D. Shepherd, Heather J. Sutherland, et al.. (2009). IPSS Poor-Risk Karyotype as a Predictor of Outcome for Patients with Myelodysplastic Syndrome following Myeloablative Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 15(2). 205–213. 17 indexed citations
18.
Shepherd, John D., Michael J. Barnett, Stephen H. Nantel, et al.. (2009). Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia Relapsing in Chronic and Advanced Phase Following Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(5). 639–646. 20 indexed citations
19.
Nevill, Thomas J., Donna E. Hogge, Cynthia L. Toze, et al.. (2008). Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML. Bone Marrow Transplantation. 42(10). 659–666. 10 indexed citations
20.
Forrest, Donna L., Ryan R. Brinkman, Michael J. Barnett, et al.. (2008). Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels. Leukemia Research. 33(2). 271–275. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catia Bigazzi Breakdown of academic impact, for papers by Carlos E. Bueso-Ramos Breakdown of academic impact, for papers by Fontanet Bijou Breakdown of academic impact, for papers by Márcia Torresan Delamain Breakdown of academic impact, for papers by Patricia Martin‐Regueira Breakdown of academic impact, for papers by Angela Volkert Breakdown of academic impact, for papers by E. Dorey Breakdown of academic impact, for papers by J. Janssen Breakdown of academic impact, for papers by Hien K. Duong
Rankless by CCL
2026